EVOLENT HEALTH INC - A (EVH) Fundamental Analysis & Valuation

NYSE:EVH • US30050B1017

Current stock price

3.75 USD
0 (0%)
At close:
3.75 USD
0 (0%)
After Hours:

This EVH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EVH Profitability Analysis

1.1 Basic Checks

  • EVH had positive earnings in the past year.
  • EVH had a positive operating cash flow in the past year.
  • In the past 5 years EVH always reported negative net income.
  • EVH had a positive operating cash flow in 4 of the past 5 years.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.51%, EVH is in line with its industry, outperforming 41.18% of the companies in the same industry.
  • The Return On Equity of EVH (-139.55%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROIC N/A
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • EVH has a Gross Margin of 21.31%. This is amonst the worse of the industry: EVH underperforms 82.35% of its industry peers.
  • EVH's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EVH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EVH Health Analysis

2.1 Basic Checks

  • EVH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EVH has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EVH has more shares outstanding
  • Compared to 1 year ago, EVH has a worse debt to assets ratio.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.25, we must say that EVH is in the distress zone and has some risk of bankruptcy.
  • EVH has a Altman-Z score (0.25) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of EVH is 204.11, which is on the high side as it means it would take EVH, 204.11 years of fcf income to pay off all of its debts.
  • EVH has a Debt to FCF ratio (204.11) which is comparable to the rest of the industry.
  • EVH has a Debt/Equity ratio of 2.34. This is a high value indicating a heavy dependency on external financing.
  • EVH's Debt to Equity ratio of 2.34 is on the low side compared to the rest of the industry. EVH is outperformed by 91.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Altman-Z 0.25
ROIC/WACCN/A
WACC8.05%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • EVH has a Current Ratio of 1.31. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.31, EVH is doing worse than 67.65% of the companies in the same industry.
  • EVH has a Quick Ratio of 1.31. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.31, EVH is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EVH Growth Analysis

3.1 Past

  • EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.36%.
  • EVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.75% yearly.
  • The Revenue for EVH has decreased by -26.56% in the past year. This is quite bad
  • EVH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.20% yearly.
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 64.70% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, EVH will show a quite strong growth in Revenue. The Revenue will grow by 18.60% on average per year.
EPS Next Y45.7%
EPS Next 2Y108.62%
EPS Next 3Y85.37%
EPS Next 5Y64.7%
Revenue Next Year32.56%
Revenue Next 2Y23.92%
Revenue Next 3Y20.2%
Revenue Next 5Y18.6%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. EVH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.67, the valuation of EVH can be described as expensive.
  • Based on the Price/Earnings ratio, EVH is valued a bit cheaper than 67.65% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EVH to the average of the S&P500 Index (26.64), we can say EVH is valued expensively.
  • With a Price/Forward Earnings ratio of 28.60, EVH can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as EVH.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. EVH is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 41.67
Fwd PE 28.6
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than 70.59% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EVH.
Industry RankSector Rank
P/FCF 88.04
EV/EBITDA 11.79
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • EVH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EVH's earnings are expected to grow with 85.37% in the coming years.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y108.62%
EPS Next 3Y85.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVH Dividend Analysis

5.1 Amount

  • EVH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVH Fundamentals: All Metrics, Ratios and Statistics

EVOLENT HEALTH INC - A

NYSE:EVH (5/1/2026, 8:24:17 PM)

After market: 3.75 0 (0%)

3.75

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Industry Strength1.24
Industry Growth47.83
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners110.54%
Inst Owner Change-0.18%
Ins Owners2.06%
Ins Owner Change3.82%
Market Cap418.65M
Revenue(TTM)1.88B
Net Income(TTM)-579.40M
Analysts83
Price Target6.01 (60.27%)
Short Float %14.83%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.5%
Min EPS beat(2)-52.63%
Max EPS beat(2)37.63%
EPS beat(4)1
Avg EPS beat(4)-69.8%
Min EPS beat(4)-226.45%
Max EPS beat(4)37.63%
EPS beat(8)3
Avg EPS beat(8)-80.44%
EPS beat(12)7
Avg EPS beat(12)-19.32%
EPS beat(16)10
Avg EPS beat(16)391.59%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.35%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)-32.38%
PT rev (3m)-35.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-177.77%
EPS NY rev (1m)-51.74%
EPS NY rev (3m)-62.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.54%
Valuation
Industry RankSector Rank
PE 41.67
Fwd PE 28.6
P/S 0.22
P/FCF 88.04
P/OCF 10.78
P/B 1.01
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)0.09
EY2.4%
EPS(NY)0.13
Fwd EY3.5%
FCF(TTM)0.04
FCFY1.14%
OCF(TTM)0.35
OCFY9.28%
SpS16.81
BVpS3.72
TBVpS-7.74
PEG (NY)0.91
PEG (5Y)N/A
Graham Number2.74428 (-26.82%)
Profitability
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.31%
FCFM 0.25%
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Debt/EBITDA 9.25
Cap/Depr 29.42%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 37.02%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 0.25
F-Score5
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)24.58%
Cap/Depr(5y)37.22%
Cap/Sales(3y)1.42%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
EPS Next Y45.7%
EPS Next 2Y108.62%
EPS Next 3Y85.37%
EPS Next 5Y64.7%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%
Revenue Next Year32.56%
Revenue Next 2Y23.92%
Revenue Next 3Y20.2%
Revenue Next 5Y18.6%
EBIT growth 1Y-324.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.62%
EBIT Next 3Y27.53%
EBIT Next 5Y21.36%
FCF growth 1Y177.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107%
OCF growth 3YN/A
OCF growth 5YN/A

EVOLENT HEALTH INC - A / EVH Fundamental Analysis FAQ

What is the fundamental rating for EVH stock?

ChartMill assigns a fundamental rating of 3 / 10 to EVH.


Can you provide the valuation status for EVOLENT HEALTH INC - A?

ChartMill assigns a valuation rating of 4 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Fairly Valued.


What is the profitability of EVH stock?

EVOLENT HEALTH INC - A (EVH) has a profitability rating of 1 / 10.


How financially healthy is EVOLENT HEALTH INC - A?

The financial health rating of EVOLENT HEALTH INC - A (EVH) is 2 / 10.


What is the expected EPS growth for EVOLENT HEALTH INC - A (EVH) stock?

The Earnings per Share (EPS) of EVOLENT HEALTH INC - A (EVH) is expected to grow by 45.7% in the next year.